ČESKÁ UROLOGIE / CZECH UROLOGY – 1 / 2023

16 Ces Urol 2023; 27(1): 8 PŘEHLEDOVÉ ČLÁNKY 12. Parwani AV, Levi AW, Epstein JI, Ali SZ. Urinary bladder biopsy with denuded mucosa: denuding cystitis‑cytopathologic correlates. Diagn Cytopathol. 2004; 30(5): 297–300. 13. Sheldon CA, Clayman RV, Gonzalez R, Williams RD, Fraley EE. Malignant urachal lesions. J Urol. 1984; 131(1): 1–8. 14. Brierley JD, Gospodarowicz MK, Wittekind C. TNM Classification of malignant tumours, 8th edition. Wiley‑Blackwell; 2016: 272. 15. Idrees MT, Alexander RE, Kum JB, Cheng L. The spectrum of histopathologic findings in vesical di‑ verticulum: implications for pathogenesis and staging. Hum Pathol. 2013; 44(7): 1223–32. 16. Lloyd R, Osamura R, Kloppel G, Rosai J. WHO Classification of Tumours of Endocrine Organs (4th Edition). Lyon (France): International Agency for Research on Cancer (IARC); 2017. 17. Acosta AM, Demicco EG, Dal Cin P. Pseudosarcomatous myofibroblastic proliferations of the urinary bladder are neoplasms characterized by recurrent FN1-ALK fusions. Mod Pathol. 2021; 34(2): 469–77. 18. Babjuk M, Burger M, Compérat EM, et al. European Association of Urology Guidelines on Non‑muscle­ ‑invasive Bladder Cancer (TaT1 and Carcinoma In Situ) – 2019 Update. Eur Urol. 2019; 76(5): 639–57. VÝROČNÍ KONFERENCE ČUS ČLS JEP 11. – 13. ŘÍJNA 2023 VÝSTAVIŠTĚ ČESKÉ BUDĚJOVICE ANNUAL MEETING OF THE CZECH UROLOGICAL SOCIETY OCTOBER 11 – 13, 2023 EXHIBITION ČESKÉ BUDĚJOVICE Registrace: od 1. 4. 2023 Termín pro dodání abstrakt: 30. 6. 2023

RkJQdWJsaXNoZXIy NDA4Mjc=